Clinical review report Mifepristone and misoprostol (Mifegymiso)

The objective of this review is to perform a systematic review of the beneficial and harmful effects of a single oral dose of mifepristone 200 mg and a single buccal dose of misoprostol 800 mcg (four 200 mcg tablets) administered in a sequential regimen for the medical termination of a developing in...

Full description

Bibliographic Details
Main Author: Canadian Agency for Drugs and Technologies in Health (author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health, author, issuing body (author)
Format: eBook
Language:Inglés
Published: Ottawa, Ontario : Canadian Agency for Drugs and Technologies in Health 2017.
Subjects:
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820282606719
Description
Summary:The objective of this review is to perform a systematic review of the beneficial and harmful effects of a single oral dose of mifepristone 200 mg and a single buccal dose of misoprostol 800 mcg (four 200 mcg tablets) administered in a sequential regimen for the medical termination of a developing intrauterine pregnancy in women of child-bearing age.
Physical Description:1 online resource (1 PDF file (viii, 62 pages)) : illustrations